Modern Care Journal

Published by: Kowsar
Corrected Proof scheduled for 15 (2)

Assessing the Hepatitis C Genotype in Prisoners Infected with HCV in South Khorasan- 2014

Zohreh Azarkar 1 , Gholamreza Sharifzadeh 1 and Mohammad Fereidouni 2
Authors Information
1 Infectious Disease Researches Center, Birjand University of Medical Sciences, Birjand, IR Iran
2 Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
Warning: No corresponding author defined!
Article information
  • Modern Care Journal: , In Press (In Press); e63680
  • Published Online: April 28, 2018
  • Article Type: Research Article
  • Received: November 14, 2017
  • Revised: January 10, 2018
  • Accepted: April 10, 2018
  • DOI: 10.5812/modernc.63680

To Cite: Azarkar Z, Sharifzadeh G, Fereidouni M. Assessing the Hepatitis C Genotype in Prisoners Infected with HCV in South Khorasan- 2014, Mod Care J. Online ahead of Print ;In Press(In Press):e63680. doi: 10.5812/modernc.63680.

Abstract
Copyright © 2018, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Simmonds P. Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol. 2004;85(Pt 11):3173-88. doi: 10.1099/vir.0.80401-0. [PubMed: 15483230].
  • 2. Poynard T, Ratziu V, Benhamou Y, Opolon P, Cacoub P, Bedossa P. Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(2):211-28. [PubMed: 10890317].
  • 3. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res. 2007;37(2):101-3. doi: 10.1111/j.1872-034X.2007.00015.x. [PubMed: 17300704].
  • 4. Joukar F, Khalesi AK, Jafarshad R, Rahimabadi MS, Mansour-Ghanaei F. Distribution of hepatitis C virus genotypes in haemodialysis patients of Guilan, northern Islamic Republic of Iran. East Mediterr Health J. 2012;18(3):236-40. [PubMed: 22574476].
  • 5. Jimenez-Mendez R, Uribe-Salas F, Lopez-Guillen P, Cisneros-Garza L, Castaneda-Hernandez G. Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico. Ann Hepatol. 2010;9(1):33-9. [PubMed: 20308720].
  • 6. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther. 2005;10(1):1-11. [PubMed: 15751759].
  • 7. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558-67. doi: 10.1016/S1473-3099(05)70216-4. [PubMed: 16122679].
  • 8. Grimaldi E, Della Pepa ME, Martora F, Magliocca P, Iovene MR, Coppola N, et al. Distribution of Hepatitis C Virus Genotypes and Subtypes in the Metropolitan Area of Naples, Italy, in the Era of Interferon-Free Regimens. Intervirology. 2017;60(3):82-9. doi: 10.1159/000481821. [PubMed: 29161710].
  • 9. Acero Fernandez D, Ferri Iglesias MJ, Buxo Pujolras M, Lopez Nunez C, Serra Matamala I, Queralt Moles X, et al. Changes in the epidemiology and distribution of the hepatitis C virus genotypes in North-Eastern Spain over the last 35 years. Gastroenterol Hepatol. 2018;41(1):2-11. doi: 10.1016/j.gastrohep.2017.09.004. [PubMed: 29150360].
  • 10. Ray S, Thomas DL. Hepatitis C. In: Mandell GL, Bennet J, Dolin R, editors. Principle and practice of infectious disease. Philadelphia: Elsevier-churcilllivingstone; 2015. p. 1908-27.
  • 11. Vahdat K, Amini A, Motamed N, Eghbali SS, Zandi K, Hajiani G. Determination of Hepatit C genotype and risk factors of transmission in Bushehr province 2008. Tibb-i junub. 2012;15(1):51-8.
  • 12. Haghshenas MR, Babamahmoodi F, Rafiei AR, Vahedi V. The Correlation between HCV Genotypes and Liver Damage in HCV Patients. J Mazandaran Univ Med Sci. 2011;21(85):76-83.
  • 13. Hajiani E, Hashemi SJ, Masjedizadeh A, Shayesteh AA, Jalali F. Genotypic analysis of hepatitis C virus in khuzestan province, southwestern iran. Middle East J Dig Dis. 2011;3(2):126-30. [PubMed: 25197544]. [PubMed Central: PMC4154916].
  • 14. Azarkar Z, Sharifzadeh G. Evaluation of the prevalence of hepatitis B, hepatitis C, and HIV in inmates with drug-related convictions in Birjand, Iran in 2008. Hepat Mon. 2010;10(1):26.
  • 15. Ebrahimzadeh A, Azarkar Z, Ziaee M, Sharifzadeh G, Bijari B. Prevalence and Risk Factors of Hepatitis C Infection (HCV) in Birjand, Iran, 2014. Int J Infect. 2016;3(1). doi: 10.17795/iji-34102.
  • 16. Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, et al. Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology. 2003;37(3):600-9. doi: 10.1053/jhep.2003.50106. [PubMed: 12601358].
  • 17. Martinot-Peignoux M, Ripault MP, Maylin S, Boyer N, Giuily N, Castelnau C, et al. [618] optimal pretreatment viral load cut-off to predict treatment outcome in patients with chronic hepatitis c treated with peginterferon o-2b plus ribavirin. J Hepatol. 2007;46. S234. doi: 10.1016/s0168-8278(07)62216-8.
  • 18. Zeuzem S, Fried MW, Reddy RK, Marcellin P, Diago M, Craxi A, et al. Improving the clinical relevance of pre-treatment viral load as a predictor of sustained virological response (SVR) in patients infected with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD)(PEGASYS®) plus ribavirin (COPEGUS®). Hepatology. 2006;44:267A-8A.
  • 19. Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, Van Raden M, Herion D, et al. Hepatitis C in asymptomatic blood donors. Hepatology. 1997;26(3 Suppl 1):29S-33S. doi: 10.1002/hep.510260705. [PubMed: 9305660].
  • 20. Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology. 2000;32(3):582-7. doi: 10.1053/jhep.2000.9714. [PubMed: 10960453].
  • 21. Vogt M, Lang T, Frosner G, Klingler C, Sendl AF, Zeller A, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999;341(12):866-70. doi: 10.1056/NEJM199909163411202. [PubMed: 10498458].
  • 22. Vossughinia H, Goshayeshi L, Bayegi HR, Sima H, Kazemi A, Erfani S, et al. Prevalence of hepatitis C virus genotypes in mashhad, northeast iran. Iran J Public Health. 2012;41(9):56-61. [PubMed: 23193507]. [PubMed Central: PMC3494216].
  • 23. Selcuk H, Kanbay M, Korkmaz M, Gur G, Akcay A, Arslan H, et al. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment. Dig Dis Sci. 2006;51(8):1420-5. doi: 10.1007/s10620-005-9025-9. [PubMed: 16868830].
  • 24. Bozdayi G, Rota S, Verdi H, Derici U, Sindel S, Bali M, et al. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution]. Mikrobiyol Bul. 2002;36(3-4):291-300. Turkish. [PubMed: 12838663].
  • 25. Kabir A, Alavian SM, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp Hepatol. 2006;5:4. doi: 10.1186/1476-5926-5-4. [PubMed: 17014721]. [PubMed Central: PMC1599752].
  • 26. Somi MH, Keivani H, Ardalan MR, Farhang S, Pouri AA. Hepatitis C virus genotypes in patients with end-stage renal disease in East Azerbaijan, Iran. Saudi J Kidney Dis Transpl. 2008;19(3):461-5. [PubMed: 18445914].
  • 27. Altuglu I, Soyler I, Ozacar T, Erensoy S. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis. 2008;12(3):239-44. doi: 10.1016/j.ijid.2007.07.003. [PubMed: 17942359].
  • 28. Turkoglu S, Bozaci M, Bozfakioglu S, Kaymakoglu S, Badur S. Molecular epidemiology of hepatitis C virus in Istanbul, Turkey. J Microbiol Methods. 1996;27(1):98. doi: 10.1016/0167-7012(96)83736-5.
  • 29. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. [PubMed: 25086286].
  • 30. Tyczyno M, Halota W, Nowak W, Pawlowska M. Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz. Hepat Mon. 2014;14(5). e14559. doi: 10.5812/hepatmon.14559. [PubMed: 24910703]. [PubMed Central: PMC4030260].
  • 31. Samimi-Rad K, Hosseini M, Mobeini G, Asgari F, Alavian SM, Tahaei ME, et al. Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran. East Mediterr Health J. 2012;18(3):227-35. [PubMed: 22574475].
  • 32. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1). e7991. doi: 10.5812/hepatmon.7991. [PubMed: 23550108]. [PubMed Central: PMC3582303].
  • 33. Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, et al. [Distribution of hepatitis C virus genotypes in Jeju Island]. Korean J Hepatol. 2008;14(1):28-35. doi: 10.3350/kjhep.2008.14.1.28. [PubMed: 18367855].
  • 34. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol. 2006;78(5):569-73. doi: 10.1002/jmv.20577. [PubMed: 16555284].
  • 35. Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A, Najafi A, Rahimnia R, Asgari F, et al. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time. Arch Virol. 2012;157(10):1959-65. doi: 10.1007/s00705-012-1369-9. [PubMed: 22695769].
  • 36. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007;13(2):156-63. doi: 10.1111/j.1365-2516.2006.01415.x. [PubMed: 17286768].
  • 37. Micalessi MI, Gerard C, Ameye L, Plasschaert S, Brochier B, Vranckx R. Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005. J Med Virol. 2008;80(4):640-5. doi: 10.1002/jmv.21145. [PubMed: 18297717].
  • 38. Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, Comar M, Croce L, et al. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol. 2002;68(3):352-6. doi: 10.1002/jmv.10210. [PubMed: 12226821].
  • 39. Sharara AI, Ramia S, Ramlawi F, Fares JE, Klayme S, Naman R. Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countries. Epidemiol Infect. 2007;135(3):427-32. doi: 10.1017/S0950268806006911. [PubMed: 16848924]. [PubMed Central: PMC2870582].
  • 40. Samimi-Rad K, Nategh R, Malekzadeh R, Norder H, Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J Med Virol. 2004;74(2):246-52. doi: 10.1002/jmv.20170. [PubMed: 15332273].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments